CDK-IN-10

• Description:

  CDK-IN-10 (example 54) is a cyclin dependent kinase (CDK) inhibitor that can be used in cancer research[1].

• UNSPSC:

  12352005

• Hazard Statement:

  H302-H315-H319-H335

• Target:

  CDK

• Type:

  Reference compound

• Related Pathways:

  Cell Cycle/DNA Damage

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/cdk-in-10.html

• Purity:

  98.03

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(C1=NNC2=C1C=CC=C2)NC3=CC=C(N4CCOCC4)C=C3

• Molecular Formula:

  C18H18N4O2

• Molecular Weight:

  322.36

• Precautions:

  P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362-P403+P233-P405-P501

• References & Citations:

  [1]Valerio Berdini, et al. 1h-indazole-3-carboxamide compounds as cyclin dependent kinases (cdk) inhibitors. WO2004014864

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [660822-84-4]